I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Circulating metabolites associated with tumor hypoxia and e..:
Alessia Lodi
;
Renu Pandey
;
Jennifer Chiou
...
https://www.frontiersin.org/articles/10.3389/fonc.2022.900082/full. , 2022
Link:
https://doi.org/10.3389/fonc.2022.900082
RT Journal T1 <Title>Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:8d649ef526fa419aa6476b5269c3dcc0&Exemplar=1&LAN=DE A1 Alessia Lodi A1 Renu Pandey A1 Jennifer Chiou A1 Ayon Bhattacharya A1 Shiliang Huang A1 Xingxin Pan A1 Brandon Burgman A1 S. Stephen Yi A1 Stefano Tiziani A1 Andrew J. Brenner PB Frontiers Media S.A. YR 2022 K1 glioblastoma (GBM) K1 bevacizumab (BEV) K1 evofosfamide (TH-302) K1 metabolomics (OMICS) K1 circulating metabolites K1 enantiomers K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2022.900082/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2022.900082 DO https://doi.org/10.3389/fonc.2022.900082 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
